1. Home
  2. ERNA vs SHFS Comparison

ERNA vs SHFS Comparison

Compare ERNA & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERNA
  • SHFS
  • Stock Information
  • Founded
  • ERNA 2018
  • SHFS 2015
  • Country
  • ERNA United States
  • SHFS United States
  • Employees
  • ERNA N/A
  • SHFS N/A
  • Industry
  • ERNA Biotechnology: Pharmaceutical Preparations
  • SHFS Finance: Consumer Services
  • Sector
  • ERNA Health Care
  • SHFS Finance
  • Exchange
  • ERNA Nasdaq
  • SHFS Nasdaq
  • Market Cap
  • ERNA 10.2M
  • SHFS 9.4M
  • IPO Year
  • ERNA N/A
  • SHFS N/A
  • Fundamental
  • Price
  • ERNA $1.33
  • SHFS $4.81
  • Analyst Decision
  • ERNA
  • SHFS
  • Analyst Count
  • ERNA 0
  • SHFS 0
  • Target Price
  • ERNA N/A
  • SHFS N/A
  • AVG Volume (30 Days)
  • ERNA 201.0K
  • SHFS 2.4M
  • Earning Date
  • ERNA 11-11-2025
  • SHFS 11-11-2025
  • Dividend Yield
  • ERNA N/A
  • SHFS N/A
  • EPS Growth
  • ERNA N/A
  • SHFS N/A
  • EPS
  • ERNA N/A
  • SHFS N/A
  • Revenue
  • ERNA $488,000.00
  • SHFS $11,720,493.00
  • Revenue This Year
  • ERNA N/A
  • SHFS N/A
  • Revenue Next Year
  • ERNA N/A
  • SHFS N/A
  • P/E Ratio
  • ERNA N/A
  • SHFS N/A
  • Revenue Growth
  • ERNA 201.24
  • SHFS N/A
  • 52 Week Low
  • ERNA $1.09
  • SHFS $1.84
  • 52 Week High
  • ERNA $18.75
  • SHFS $10.78
  • Technical
  • Relative Strength Index (RSI)
  • ERNA 51.85
  • SHFS 48.33
  • Support Level
  • ERNA $1.09
  • SHFS $6.70
  • Resistance Level
  • ERNA $1.32
  • SHFS $7.58
  • Average True Range (ATR)
  • ERNA 0.10
  • SHFS 0.81
  • MACD
  • ERNA 0.03
  • SHFS -0.01
  • Stochastic Oscillator
  • ERNA 72.58
  • SHFS 29.20

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

Share on Social Networks: